Westchester Medical Center
- Type
- Teaching hospital
- Where
- VALHALLA, NY
- Medicare CCN
- 330234
- Received
- $306,071 in 51 records, 2025 ($143,761 general, $162,309 research)
- Source
- CMS Open Payments search ↗
On this site
- Federal award recipient: WESTCHESTER MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: WESTCHESTER MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: WESTCHESTER MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 38 | $143,761 |
| 2025 | Research payment | 13 | $162,309 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| PFIZER INC. | 7 | $124,284 | 2025 |
| KLS-Martin L.P. | 14 | $34,913 | 2025 |
| AngioDynamics, Inc. | 1 | $31,000 | 2025 |
| W. L. Gore & Associates, Inc. | 4 | $21,035 | 2025 |
| Rapid Medical Ltd | 2 | $16,990 | 2025 |
| Medical Device Business Services, Inc. | 1 | $15,000 | 2025 |
| Medtronic, Inc. | 1 | $15,000 | 2025 |
| MicroVention, Inc. | 1 | $10,000 | 2025 |
| Advanced Bionics, LLC | 1 | $9,925 | 2025 |
| Amgen Inc. | 3 | $7,170 | 2025 |
| National Marrow Donor Program | 4 | $5,570 | 2025 |
| UCB, Inc. | 1 | $5,000 | 2025 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $3,500 | 2025 |
| icotec Medical Inc. | 1 | $3,000 | 2025 |
| Stryker Corporation | 3 | $2,259 | 2025 |
| Zimmer Biomet Holdings, Inc. | 5 | $1,272 | 2025 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $150 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 13 | $162,309 |
| Space rental or facility fees (teaching hospital only) | 8 | $55,670 |
| Debt forgiveness | 17 | $37,087 |
| Long term medical supply or device loan | 2 | $31,236 |
| Grant | 2 | $12,925 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 4 | $5,570 |
| Food and Beverage | 5 | $1,272 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | AngioDynamics, Inc. | $31,000 | Long term medical supply or device loan | In-kind items and services | NanoKnife Device, Oncology Surgery | 2025 | |
| 2025-12-31 | Stryker Corporation | $1,669 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-12-31 | Stryker Corporation | $354 | Debt forgiveness | Cash or cash equivalent | 2025 | ||
| 2025-12-31 | Stryker Corporation | $236 | Long term medical supply or device loan | In-kind items and services | SLEEPER BENCH Device, FURNITURE | 2025 | |
| 2025-12-19 | KLS-Martin L.P. | $5,594 | Debt forgiveness | Cash or cash equivalent | IPS, MODEL, MAXILLA AND CRANIUM, CRYSTAL, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-19 | KLS-Martin L.P. | $3,483 | Debt forgiveness | Cash or cash equivalent | IPS, CUTTING GUIDE, ORTHOG, COMPLEX, 00163, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-19 | KLS-Martin L.P. | $2,971 | Debt forgiveness | Cash or cash equivalent | IPS, MODEL, MANDIBLE, CRYSTAL, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-19 | KLS-Martin L.P. | $2,971 | Debt forgiveness | Cash or cash equivalent | IPS, MODEL, MANDIBLE, CRYSTAL, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-19 | KLS-Martin L.P. | $2,881 | Debt forgiveness | Cash or cash equivalent | IPS, MODEL, MAXILLA, CRYSTAL, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-19 | KLS-Martin L.P. | $2,488 | Debt forgiveness | Cash or cash equivalent | IPS, IMPLANT, MAND/ORTHOG, 00067, LP, TI-6AL-4V, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-19 | KLS-Martin L.P. | $1,849 | Debt forgiveness | Cash or cash equivalent | IPS, SPLINT, ORTHOG, DOUBLE JAW, SET, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-19 | KLS-Martin L.P. | $1,254 | Debt forgiveness | Cash or cash equivalent | IPS, SUPPLEMENTAL MODEL, HALF, 00006, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-19 | KLS-Martin L.P. | $1,241 | Debt forgiveness | Cash or cash equivalent | IPS, IMPLANT, MIDFACE/ORTHOG, 00072, LP, TI-6AL-4V, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-12-16 | PFIZER INC. | $2,000 | Research payment | In-kind items and services | ELREXFIO Drug, ONCOLOGY | A PHASE 3 OPENLABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB POMALIDOMIDE DEXAMETHASONE EPD OR POMALIDOMIDE BO | 2025 |
| 2025-11-17 | PFIZER INC. | $35,371 | Research payment | In-kind items and services | ELREXFIO Drug, ONCOLOGY | A PHASE 3 OPENLABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB POMALIDOMIDE DEXAMETHASONE EPD OR POMALIDOMIDE BO | 2025 |
| 2025-10-28 | Zimmer Biomet Holdings, Inc. | $285 | Food and Beverage | In-kind items and services | A&E MEDICAL / STERNALOCK XP RIGID FIXATION SYSTEM Device, CMF & Thoracic | 2025 | |
| 2025-10-27 | Zimmer Biomet Holdings, Inc. | $280 | Food and Beverage | In-kind items and services | A&E MEDICAL / STERNALOCK XP RIGID FIXATION SYSTEM Device, CMF & Thoracic | 2025 | |
| 2025-10-20 | PFIZER INC. | $30,341 | Research payment | In-kind items and services | ELREXFIO Drug, ONCOLOGY | A PHASE 3 OPENLABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB POMALIDOMIDE DEXAMETHASONE EPD OR POMALIDOMIDE BO | 2025 |
| 2025-10-17 | National Marrow Donor Program | $1,045 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-17 | W. L. Gore & Associates, Inc. | $750 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | Evaluation of the GORE Ascending Stent Graft in the Treatment of Isolated Lesions, Pseudoaneurysms, and Penetrating Aort | 2025 |
| 2025-10-17 | Zimmer Biomet Holdings, Inc. | $247 | Food and Beverage | In-kind items and services | A&E MEDICAL / STERNALOCK XP RIGID FIXATION SYSTEM Device, CMF & Thoracic | 2025 | |
| 2025-10-17 | Zimmer Biomet Holdings, Inc. | $129 | Food and Beverage | In-kind items and services | TraumaOne Device, CMF & Thoracic | 2025 | |
| 2025-10-09 | Zimmer Biomet Holdings, Inc. | $330 | Food and Beverage | In-kind items and services | Doublewire Sternum Sutures Device, CMF & Thoracic | 2025 | |
| 2025-08-13 | Amgen Inc. | $170 | Space rental or facility fees (teaching hospital only) | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-08 | W. L. Gore & Associates, Inc. | $18,785 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Post-Approval Study | 2025 |
| 2025-08-01 | W. L. Gore & Associates, Inc. | $750 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | Evaluation of the GORE Ascending Stent Graft in the Treatment of Isolated Lesions, Pseudoaneurysms, and Penetrating Aort | 2025 |
| 2025-07-31 | LANTHEUS MEDICAL IMAGING, INC. | $150 | Debt forgiveness | In-kind items and services | 2025 | ||
| 2025-07-25 | National Marrow Donor Program | $1,995 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-06-27 | KLS-Martin L.P. | $4,436 | Debt forgiveness | Cash or cash equivalent | IPS, MARKING GUIDE, W/PLANNING, DISTRACTION, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-06-27 | KLS-Martin L.P. | $2,881 | Debt forgiveness | Cash or cash equivalent | IPS, MODEL, MAXILLA, CRYSTAL, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-06-27 | KLS-Martin L.P. | $1,261 | Debt forgiveness | Cash or cash equivalent | IPS, MARKING GUIDE, DISTRACTION, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-06-27 | KLS-Martin L.P. | $1,254 | Debt forgiveness | Cash or cash equivalent | IPS, SUPPLEMENTAL MODEL, HALF, 00006, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-06-27 | KLS-Martin L.P. | $344 | Debt forgiveness | Cash or cash equivalent | IPS, SPLINT, ORTHOG, SUPPLEMENTAL, LP, QTY: 001 EA Device, Osteosynthesis | 2025 | |
| 2025-06-09 | UCB, Inc. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-06-05 | icotec Medical Inc. | $3,000 | Grant | Cash or cash equivalent | VADER PEDICLE SYSTEM 6.0, SCREW, Carbon/PEEK, POLYAX., FEN., O 5.5 X 45 MM Device, SPINAL STABILIZATION | 2025 | |
| 2025-05-23 | W. L. Gore & Associates, Inc. | $750 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | Evaluation of the GORE Ascending Stent Graft in the Treatment of Isolated Lesions, Pseudoaneurysms, and Penetrating Aort | 2025 |
| 2025-05-22 | Medtronic, Inc. | $15,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-05-19 | Rapid Medical Ltd | $15,990 | Research payment | Cash or cash equivalent | TIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, Neurovascular | Cognitive | 2025 |
| 2025-05-14 | Medical Device Business Services, Inc. | $15,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CEREPAK UNIFORM Device, Neurovascular | 2025 | |
| 2025-05-14 | Johnson & Johnson Surgical Vision, Inc. | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | TECNIS IOL Device, Optics | 2025 | |
| 2025-04-25 | National Marrow Donor Program | $1,070 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-04-23 | MicroVention, Inc. | $10,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-04-22 | PFIZER INC. | $2,000 | Research payment | In-kind items and services | ELREXFIO Drug, ONCOLOGY | A PHASE 3 OPENLABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB POMALIDOMIDE DEXAMETHASONE EPD OR POMALIDOMIDE BO | 2025 |
| 2025-04-09 | Amgen Inc. | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-02 | PFIZER INC. | $28,297 | Research payment | In-kind items and services | ELREXFIO Drug, ONCOLOGY | A PHASE 3 OPENLABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB POMALIDOMIDE DEXAMETHASONE EPD OR POMALIDOMIDE BO | 2025 |
| 2025-04-02 | PFIZER INC. | $24,273 | Research payment | In-kind items and services | ELREXFIO Drug, ONCOLOGY | A PHASE 3 OPENLABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB POMALIDOMIDE DEXAMETHASONE EPD OR POMALIDOMIDE BO | 2025 |
| 2025-04-02 | PFIZER INC. | $2,000 | Research payment | In-kind items and services | ELREXFIO Drug, ONCOLOGY | A PHASE 3 OPENLABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB POMALIDOMIDE DEXAMETHASONE EPD OR POMALIDOMIDE BO | 2025 |
| 2025-03-26 | Amgen Inc. | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-01-24 | National Marrow Donor Program | $1,460 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-01-14 | Advanced Bionics, LLC | $9,925 | Grant | Cash or cash equivalent | HIRES ULTRA CI HIFOCUS MS ELECTRODE Device, OTOLARYNGOLOGY | 2025 | |
| 2025-01-02 | Rapid Medical Ltd | $1,000 | Research payment | Cash or cash equivalent | TIGERTRIEVER 17 REVASCULARIZATION DEVICE Device, Neurovascular | Cognitive | 2025 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Valhalla, NY, county Westchester County, NY, state New York; placed by its city name.
| Measure | Place (city or town) Valhalla, NY | County Westchester County, NY | State New York |
|---|---|---|---|
| Population B01003 | 2,937 | 999,677 | 19,852,366 |
| Population, 2020 census P1 | 3,213 | 1,004,457 | 20,201,249 |
| Median age B01002 | 47.8 | 41.8 | 39.8 |
| Under 18 B01001 | 19.5% | 21.3% | 20.5% |
| 65 and over B01001 | 23.9% | 18.2% | 17.9% |
| Households B11001 | 1,047 | 372,883 | 7,722,646 |
| Foreign born B05002 | 17.5% | 26.1% | 22.8% |
| Median household income B19013 | $134,037 | $118,976 | $85,974 |
| Median family income B19113 | $162,917 | $156,822 | $106,873 |
| Per capita income B19301 | $58,907 | $72,705 | $50,712 |
| Poverty rate B17001 | 9.4% | 9.0% | 14.0% |
| Unemployment rate B23025 | 1.9% | 6.1% | 6.4% |
| Civilian labor force B23025 | 1,363 | 529,476 | 10,171,766 |
| Mean commute (minutes) B08013 | 21.4 | 34.6 | 32.6 |
| Bachelor's degree or higher B15003 | 44.1% | 53.1% | 40.2% |
| Housing units B25001 | 1,171 | 394,358 | 8,585,241 |
| Owner-occupied B25003 | 89.7% | 61.8% | 54.3% |
| Renters B25003 | 10.3% | 38.2% | 45.7% |
| Median home value B25077 | $663,500 | $663,200 | $423,800 |
| Median gross rent B25064 | $3,167 | $1,951 | $1,621 |
| White, not Hispanic B03002 | 69.3% | 49.2% | 52.8% |
| Black B03002 | 1.9% | 12.7% | 13.4% |
| Hispanic or Latino B03002 | 21.8% | 27.4% | 19.8% |
| Asian B03002 | 5.1% | 6.2% | 9.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Valhalla, NY.
Comments